CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project focuses on enhancing drug discovery for neglected diseases like malaria and tuberculosis by fostering collaboration among researchers in an open environment. It supports experienced researchers through continuous funding, enabling them to access resources at the GlaxoSmithKline facility in Spain and promote…
Scientific Area:
Health, Research, Drug Discovery, Neglected diseases:
Malaria, Tuberculosis and other Neglected Diseases.Beneficiary:
Tres Cantos Open Lab Foundation (UK Charity).Geographical Scope:
Worldwide.Duration: 5 years Continuous call with evaluations each 6 months.Researchers: 19.
Maximum duration of contracts: 2 years.
Mobility:
Incoming.Home (sending) Institutions:
High Education Institutions and Private Companies in the field of Neglected Diseases Research worldwide.Host Institutio…
TRES CANTOS OPEN LAB FOUNDATION LBG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.